← All medicines
Adjupanrix suspension and emulsion for emulsion for injection. Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted)
Licence EU/1/09/578/001 · Unknown
- Licence holder
- GlaxoSmithKline Biologicals S.A. (all products →)
- Active substance
- Purified antigen fractions of inactivated split virions a/vietnam/1194/2004 nibrg-14 (h5n1)
- Dosage form
- Emulsion and suspension for emulsion for injection
- Route of administration
- Intramuscular use
- ATC codes
- J07BB, J07BB02
- First authorised
- 05/11/2009
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- Full application (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.